Cargando…
Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374633/ https://www.ncbi.nlm.nih.gov/pubmed/18304374 http://dx.doi.org/10.1186/cc6774 |
| _version_ | 1782154499571318784 |
|---|---|
| author | Keene, Adam Kawano, Thomas Anees, Syed Chen, Julie |
| author_facet | Keene, Adam Kawano, Thomas Anees, Syed Chen, Julie |
| author_sort | Keene, Adam |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2374633 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23746332008-05-09 Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease Keene, Adam Kawano, Thomas Anees, Syed Chen, Julie Crit Care Letter BioMed Central 2008 2008-02-11 /pmc/articles/PMC2374633/ /pubmed/18304374 http://dx.doi.org/10.1186/cc6774 Text en Copyright © 2008 BioMed Central Ltd |
| spellingShingle | Letter Keene, Adam Kawano, Thomas Anees, Syed Chen, Julie Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease |
| title | Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease |
| title_full | Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease |
| title_fullStr | Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease |
| title_full_unstemmed | Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease |
| title_short | Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease |
| title_sort | increased bleeding risk associated with the use of recombinant human activated protein c in patients with advanced liver disease |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374633/ https://www.ncbi.nlm.nih.gov/pubmed/18304374 http://dx.doi.org/10.1186/cc6774 |
| work_keys_str_mv | AT keeneadam increasedbleedingriskassociatedwiththeuseofrecombinanthumanactivatedproteincinpatientswithadvancedliverdisease AT kawanothomas increasedbleedingriskassociatedwiththeuseofrecombinanthumanactivatedproteincinpatientswithadvancedliverdisease AT aneessyed increasedbleedingriskassociatedwiththeuseofrecombinanthumanactivatedproteincinpatientswithadvancedliverdisease AT chenjulie increasedbleedingriskassociatedwiththeuseofrecombinanthumanactivatedproteincinpatientswithadvancedliverdisease |